Bristol Myers Squibb is leaning heavily on its newer key products, grouped into its growth portfolio category, to weather the storm it expects as it heads toward further declines within its legacy | ...

After notching its fifth straight record-breaking sales year in the US, Hyundai has no plans of slowing down. The ...

Footage of Cardi's "Pretty & Petty" performance from the opening night of the Little Miss Drama Tour went viral.

A new study highlights the critical role of advanced AI-integrated battery management system technologies in monitoring, optimizing, and predicting battery performance for reliable and sustainable ...

Biosimilar natalizumab (Tyruko) is approved by EMA, US FDA, MHRA etc. and article is intended only for the HCP audience in ...

Verisk, a global data analytics and technology provider to the insurance industry, has estimated insured industry losses to ...

If you recently became an EV owner, you might have wondered if it is ok to add aftermarket accessories to your new vehicle.

BMY Q4 2025 earnings call recap: growth portfolio momentum, pipeline catalysts, 2026 guidance, and Eliquis LOE risks.

In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to ...

Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...